Effect of Growth Hormone on Insulin Signaling in Muscle Tissue
NCT ID: NCT00477997
Last Updated: 2009-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8 participants
INTERVENTIONAL
2007-05-31
2008-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle
NCT03878992
Growth Hormone Signaling in Vivo in Humans
NCT00512473
Metabolic Studies- Interactions Between GH and Insulin in GHDA
NCT00568568
Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content
NCT00476879
Ghrelin, Growth Hormone and Cortisol Interaction in Growth Hormone Deficient Patients
NCT00139945
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Saline bolus + OGTT
Physiological Bolus of Growth Hormone
0,5 mg Norditropin
2
GH-bolus and OGTT
Physiological Bolus of Growth Hormone
0,5 mg Norditropin
3
GH-bolus
Physiological Bolus of Growth Hormone
0,5 mg Norditropin
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physiological Bolus of Growth Hormone
0,5 mg Norditropin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy
* Age between 18 and 30 years
* BMI ≤ 26
Exclusion Criteria
* BMI \> 26
* Uses any medication
* Consumes \> 21 units of alcohol per week
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aarhus University Hospital
OTHER
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aarhus University Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jens Otto L Jørgensen, MD, DMSc
Role: PRINCIPAL_INVESTIGATOR
Department M (endocrinology and diabetes), Aarhus University Hospital, Norrebrogade 44, 8000 Aarhus C, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department M (endocrinology and diabetes)
Aarhus, Aarhus, Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Krusenstjerna-Hafstrom T, Madsen M, Vendelbo MH, Pedersen SB, Christiansen JS, Moller N, Jessen N, Jorgensen JO. Insulin and GH signaling in human skeletal muscle in vivo following exogenous GH exposure: impact of an oral glucose load. PLoS One. 2011 May 3;6(5):e19392. doi: 10.1371/journal.pone.0019392.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MM-GH-20070052
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.